Veriteq Corporation is a medical technology holding company that operates as an online retailer of orthopedic braces and physical therapy and rehabilitation equipment through its subsidiary, Brace Shop, LLC (Brace Shop). Brace Shop operates as an online retailer of orthopedic braces and supports in various categories, such as knee, ankle, back, wrist, shoulder, elbow, foot and neck; physical therapy and rehabilitation equipment, such as hot and cold therapy, electric stimulation, medical tables and ambulatory devices. Brace Shop directly distributes products to a range of customers in various industries and fields, including healthcare professionals, hospitals, physical therapy and rehabilitation clinics, government institutions and school athletic programs. Brace Shop primarily distributes these products to the general public through its Website www.braceshop.com.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: N/A
- Sub-Industry: N/A
- Symbol: OTCMKTS:VTEQ
- CUSIP: N/A
- Web: www.veriteqcorp.com
- 50 Day Moving Avg: $0.21
- 200 Day Moving Avg: $0.83
- 52 Week Range: $0.04 - $0.22
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Annual Revenue: $6.8 million
- Price / Sales: 0.02
- Book Value: ($19.64) per share
- Price / Book: -0.01
- Average Volume: 7,800 shs.
- Beta: 3.02
- Short Ratio: 0.07
Frequently Asked Questions for VeriTeQ Corp. (OTCMKTS:VTEQ)
What is VeriTeQ Corp.'s stock symbol?
VeriTeQ Corp. trades on the OTCMKTS under the ticker symbol "VTEQ."
When will VeriTeQ Corp. make its next earnings announcement?
Who are some of VeriTeQ Corp.'s key competitors?
Some companies that are related to VeriTeQ Corp. include Johnson & Johnson (JNJ), Roche Holding (RHHBY), Pfizer (PFE), Novartis AG (NVS), UnitedHealth Group Incorporated (UNH), Merck & Company (MRK), Amgen (AMGN), Sanofi (SNY), AbbVie (ABBV), Novo Nordisk A/S (NVO), Bayer AG (BAYRY), Medtronic PLC (MDT), Gilead Sciences (GILD), GlaxoSmithKline PLC (GSK), Bristol-Myers Squibb Company (BMY), Abbott Laboratories (ABT), Eli Lilly and Company (LLY) and Allergan PLC. (AGN).
Who are VeriTeQ Corp.'s key executives?
VeriTeQ Corp.'s management team includes the folowing people:
- Randolph K. Geissler, President
- Kenneth Shapiro, Chief Executive Officer, Chief Financial Officer, Director
- Barry M. Edelstein, Director
- Michael C. James, Director
- Lynne Shapiro, Director
How do I buy VeriTeQ Corp. stock?
Shares of VeriTeQ Corp. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is VeriTeQ Corp.'s stock price today?
MarketBeat Community Rating for VeriTeQ Corp. (OTCMKTS VTEQ)MarketBeat's community ratings are surveys of what our community members think about VeriTeQ Corp. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of VeriTeQ Corp. stock can currently be purchased for approximately $0.15.
Consensus Ratings for VeriTeQ Corp. (OTCMKTS:VTEQ) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for VeriTeQ Corp. (OTCMKTS:VTEQ)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for VeriTeQ Corp. (OTCMKTS:VTEQ)Earnings History by Quarter for VeriTeQ Corp. (OTCMKTS VTEQ)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/16/2018|| || || || || || || || |
|5/14/2014||($0.13)||$0.09||$71.80 million||$0.07 million||View||N/A|
Earnings Estimates for VeriTeQ Corp. (OTCMKTS:VTEQ)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for VeriTeQ Corp. (OTCMKTS:VTEQ)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for VeriTeQ Corp. (OTCMKTS:VTEQ)
Insider Ownership Percentage: 8.60%Insider Trades by Quarter for VeriTeQ Corp. (OTCMKTS:VTEQ)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|8/25/2014||Daniel E Penni||Director||Buy||250,000||$0.02||$5,000.00|| |
Headline Trends for VeriTeQ Corp. (OTCMKTS:VTEQ)
Latest Headlines for VeriTeQ Corp. (OTCMKTS:VTEQ)
VeriTeQ Corp. (VTEQ) Chart for Thursday, August, 24, 2017